More on EPCT
Data
Financials
News
|
EpiCept Corporation (OP:EPCT)
Delayed: 0.07
+0.01 (16.67%)
|
Trade Now! |
|
||||
|---|---|---|---|---|---|---|
| Previous Close | $0.06 | 52 Week High | $0.23 | |||
| Open | $0.07 | 52 Week Low | $0.03 | |||
| Day High | $0.07 | P/E | N/A | |||
| Day Low | $0.07 | EPS | $-0.21 | |||
| Volume | 351,078 | |||||
- EpiCept Issues Notice of Special Meeting of Stockholders on August 6 to Approve Important Aspects of the Proposed Merger with Immune Pharmaceuticals
- Form 8-K EPICEPT CORP For: Jun 17
- EpiCept Announces New Crolibulin Data Presented at ASCO 2013 Support Further Evaluation in Anaplastic Thyroid Cancer
- CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013
- Form 10-Q EPICEPT CORP For: Mar 31
- Form 8-K EPICEPT CORP For: May 20
- EpiCept Reports First Quarter 2013 Operating and Financial Results
- Form NT 10-Q EPICEPT CORP For: Mar 31
Entities mentioned with EPCT
- Earnings | View Related Stories »
- Morning Movers | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- 3Par/Dell/HP | View Related Stories »
- Ramius Capital | View Related Stories »
- Dividend | View Related Stories »
- Ensco plc/Pride International | View Related Stories »
- Kindred Healthcare/RehabCare Group | View Related Stories »
- Show More...
